Search
for
Sort by
Research 30 of 1000+
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Fast clinical response with topical ruxolitinib in the management of non-segmental vitiligo detected by VISIA<sup>®</sup> analysis system
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- Topical Ruxolitinib for Folliculitis Decalvans
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Topical Drugs Regrow Hair In Mice
- 691 Topical curcumin promotes induction of the murine hair cycle
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience
- Alopecia Areata: An Update on Treatment Options for Children
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- JAK inhibitors in dermatology: The promise of a new drug class
- New drugs under investigation for the treatment of alopecias
- A review of Janus kinase inhibitor use in scarring alopecia
- Alopecia Areata and Alopecia Areata Incognita
- Vitiligo—Current Treatment Options and Future Perspectives
- Treatment of Alopecia Areata and Its Numerous Possibilities: A Literature Review
- Janus kinase inhibitors for alopecia areata: A narrative review
- Alopecia areata – Current understanding and management
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata